Abilify Long-Acting Injectables
Abilify Maintena and Asimtufii are maintenance treatments for patients with bipolar 1 disorder.
What are Abilify long-acting injectables?
Abilify Maintena and Abilify Asimtufii are medications used for the treatment of bipolar 1 disorder and schizophrenia. Patients often choose these long-acting injectables to decrease the odds of a relapse of their illness.
These long-acting forms of aripiprazole eliminate the need for the daily oral medication in appropriate patients. Patients have been shown to remain mood episode-free for significantly longer than those on a placebo.
Maintena is administered once monthly, and Asimtufii is administered once-every-two-months.
Before starting Abilify Maintena or Abilify Asimtufii, it’s important that you’ve already taken aripiprazole by mouth without any serious side effects.
Progressive Therapies for Difficult to Treat Mental Illness
Depression is the leading cause of disability worldwide, with about 9.5 percent of adults in the United States experiencing it annually. When individuals suffer from depression that remains unresponsive to conventional treatments, novel therapies often can improve outcomes.